First Acceptance Co. (OTCMKTS:FACO – Get Free Report) was the recipient of a significant decrease in short interest during the month of November. As of November 30th, there was short interest totalling 400 shares, a decrease of 33.3% from the November 15th total of 600 shares. Based on an average trading volume of 6,800 shares, the days-to-cover ratio is presently 0.1 days.
First Acceptance Price Performance
Shares of OTCMKTS:FACO opened at $3.20 on Friday. First Acceptance has a one year low of $1.90 and a one year high of $4.35. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.57 and a quick ratio of 0.57. The company has a market cap of $122.08 million, a price-to-earnings ratio of 1.53 and a beta of 0.18. The firm has a 50 day simple moving average of $3.40 and a 200 day simple moving average of $3.59.
First Acceptance (OTCMKTS:FACO – Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.14 earnings per share (EPS) for the quarter. First Acceptance had a net margin of 12.41% and a return on equity of 53.03%. The company had revenue of $129.26 million during the quarter.
First Acceptance Company Profile
First Acceptance Corporation, together with its subsidiaries, operates as a retailer, servicer, and underwriter of non-standard personal automobile insurance and related products in the United States. It issues non-standard automobile insurance policies to individuals based on their inability or unwillingness to obtain insurance coverage from standard carriers due to various factors, including their payment preference, failure to maintain continuous insurance coverage, or driving record.
Featured Stories
- Five stocks we like better than First Acceptance
- ETF Screener: Uses and Step-by-Step Guide
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Health Care Stocks Explained: Why You Might Want to Invest
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for First Acceptance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Acceptance and related companies with MarketBeat.com's FREE daily email newsletter.